Skip to main content
. 2021 Jan 6;60(9):4199–4204. doi: 10.1093/rheumatology/keaa908

Table 3.

Manifestation scores for febuxostat vs placebo at baseline, days 1, 3, 5 and 7

Parameters Placebo, mean (s.d.) Febuxostat, mean (s.d.) P a
Joint pain score
 Baseline 2.87 (0.99) 2.89 (0.99) 0.932
 day 1 2.01 (1.20) 1.93 (1.22) 0.601
 day 3 1.09 (1.01) 0.97 (1.04) 0.383
 day 5 0.51 (0.65) 0.67 (0.81) 0.319
 day 7 0.13 (0.42) 0.26 (0.50) 0.057
Joint swelling score
 Baseline 1.99 (0.88) 1.93 (0.87) 0.726
 day 1 1.69 (0.93) 1.50 (0.96) 0.219
 day 3 0.85 (0.79) 0.75 (0.76) 0.454
 day 5 0.45 (0.63) 0.41 (0.55) 0.848
 day 7 0.13 (0.34) 0.20 (0.47) 0.468
Joint tenderness score
 Baseline 1.61 (0.49) 1.60 (0.55) 0.970
 day 1 1.36 (0.57) 1.22 (0.65) 0.207
 day 3 0.73 (0.59) 0.58 (0.58) 0.149
 day 5 0.38 (0.49) 0.45 (0.53) 0.458
 day 7 0.14 (0.38) 0.19 (0.43) 0.387
Joint erythema score
 Baseline 1.46 (0.63) 1.40 (0.69) 0.704
 day 1 1.14 (0.80) 1.00 (0.74) 0.288
 day 3 0.46 (0.56) 0.38 (0.57) 0.283
 day 5 0.26 (0.44) 0.30 (0.49) 0.659
 day 7 0.10 (0.30) 0.15 (0.39) 0.550
a

Calculated from Mann–Whitney U test.